DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr | ₹41 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-1,045 Cr |
Mar2022 | ₹-816 Cr |
Mar2021 | ₹1,987 Cr |
Mar2020 | ₹41 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-1,045 Cr | Negative | |
Mar2022 | ₹-816 Cr | Negative | |
Mar2021 | ₹1,987 Cr | 4,740.85 | |
Mar2020 | ₹41 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹185,631.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics | |
MANKIND PHARMA | ₹104,226.0 Cr | 6.9% | 6.2% | 13.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.8% |
4.8% |
49.8% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses